Pet Metabolic & Endocrine Disorder Research & Development Service
Metabolic and endocrine disorders, including diabetes, obesity, and thyroid disease, are increasingly common in companion animals, impacting their quality of life and longevity. The development of novel therapeutics to manage these complex conditions requires deep expertise and specialized preclinical models. Creative Biolabs is your dedicated CRO partner, offering a comprehensive, one-stop solution to navigate the challenges of veterinary metabolic and endocrine research. We empower biotech and pharmaceutical companies to accelerate their R&D pipeline, from initial target discovery to preclinical validation, with scientifically rigorous and species-appropriate services. Partner with us to transform promising concepts into effective treatments that enhance the health and well-being of pets.
Our Pet Metabolic & Endocrine Disorder R&D Capabilities
Accelerate your therapeutic pipeline with our end-to-end preclinical services, specifically designed to address the complexities of canine and feline metabolic and endocrine diseases. We provide a suite of validated platforms and customizable assays to generate decision-driving data at every stage of development.
Biomarker & Target Identification
We use metabolomic, proteomic, and gene expression analysis to discover novel targets and biomarkers. Our receptor signaling assays clarify your compound's mechanism of action.
In Vitro Metabolic Assays
We evaluate therapeutics at the cellular level using glucose uptake assays, adipocyte and hepatocyte functional studies, and hormone secretion assays.
Companion Animal In Vivo Models
Our clinically relevant models include spontaneous and induced diabetes in dogs and cats, diet-induced obesity (DIO), and models for specific endocrine disorders like Cushing's disease.
Preclinical Efficacy & Safety
We conduct glucose and insulin tolerance tests, full pharmacokinetic (PK) and pharmacodynamic (PD) profiling, and comprehensive safety and toxicology studies to ensure your program is ready for its next steps.
Service Workflow
Our pet metabolic & endocrine disorder R&D service supports the discovery and preclinical development of therapies targeting obesity, diabetes, thyroid disease, Cushing's syndrome, and other endocrine or metabolic disorders in companion animals. With species-relevant models and end-to-end study execution, we deliver reliable data to accelerate veterinary therapeutic innovation.
| Workflow | Description |
|---|---|
| Study Planning | We begin by understanding your scientific objectives, therapeutic modality, and specific research questions to develop a strategic plan. |
| Custom Study Design | Our scientists collaborate directly with your team to design a custom protocol. We ensure the study is scientifically rigorous and perfectly tailored to your specific research questions. |
| Dedicated Project Execution | A dedicated project manager oversees all study activities, providing regular progress updates and ensuring adherence to timelines and quality standards. |
| Data Analysis & Reporting | You'll receive a comprehensive final report containing clear, high-quality data. We provide expert analysis and interpretation to help you make confident, data-driven decisions for your program's next phase. |
Our Advantages
Applications
We offer the flexibility to support your project at any stage, whether you require a single, specialized assay or a complete, integrated preclinical package. Our project management team ensures smooth execution and clear communication, providing a reliable foundation for your R&D efforts. We are equipped to handle a diverse array of therapeutic modalities, from small molecules and peptides to biologics and gene therapies, providing the robust, high-quality data you need to make critical decisions with confidence. Our services support the development of therapies for a wide range of metabolic and endocrine disorders in pets, including:
- Diabetes Mellitus
- Obesity and Weight Management
- Hypothyroidism and Hyperthyroidism
- Hyperadrenocorticism
- Hypoadrenocorticism
- Lipid Disorders
Partner with Creative Biolabs
Choosing Creative Biolabs means gaining a strategic ally dedicated to advancing veterinary medicine. Our specialized services in metabolic and endocrine disorders help you de-risk your program, shorten development timelines, and bring life-changing therapies to the pets who need them. Let us help you turn your scientific innovations into tangible solutions.
Ready to advance your research? Contact Creative Biolabs today to discuss your project needs with our scientific experts. Together, we can improve the standard of care for pets with metabolic and endocrine diseases.